KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to 0.5.

  • Bristol Myers Squibb's Debt Ratio fell 655.18% to 0.5 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.5, marking a year-over-year decrease of 655.18%. This contributed to the annual value of 0.5 for FY2025, which is 655.18% down from last year.
  • Bristol Myers Squibb's Debt Ratio amounted to 0.5 in Q4 2025, which was down 655.18% from 0.51 recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Debt Ratio peaked at 0.56 during Q1 2024, and registered a low of 0.4 during Q3 2022.
  • In the last 5 years, Bristol Myers Squibb's Debt Ratio had a median value of 0.42 in 2022 and averaged 0.46.
  • Per our database at Business Quant, Bristol Myers Squibb's Debt Ratio plummeted by 807.14% in 2023 and then skyrocketed by 4011.75% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Debt Ratio stood at 0.41 in 2021, then decreased by 0.36% to 0.41 in 2022, then grew by 2.92% to 0.42 in 2023, then grew by 28.28% to 0.54 in 2024, then dropped by 6.55% to 0.5 in 2025.
  • Its Debt Ratio stands at 0.5 for Q4 2025, versus 0.51 for Q3 2025 and 0.52 for Q2 2025.